ENVB logo

Enveric Biosciences (ENVB)

Profile

Full Name

Enveric Biosciences, Inc.

Ticker Symbol

ENVB

Exchange

NASDAQ

Country

United States

IPO

May 4, 2015

Indexes

Not included

Employees

5

Key Details

Price

$1.38(+3.37%)

Market cap

Last Dividend

$277.34K

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$19.04(+84.30% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 6, 25 HC Wainwright & Co.
Buy
Jan 30, 24 HC Wainwright & Co.
Buy
Jun 1, 22 Alliance Global Partners
Buy
Mar 8, 22 Aegis Capital
Hold
Jul 8, 21 Aegis Capital
Buy
Jun 28, 21 Maxim Group
Buy

Institutional Ownership

  • What is the ticker symbol for Enveric Biosciences?
  • Does Enveric Biosciences pay dividends?
  • What sector is Enveric Biosciences in?
  • What industry is Enveric Biosciences in?
  • What country is Enveric Biosciences based in?
  • When did Enveric Biosciences go public?
  • Is Enveric Biosciences in the S&P 500?
  • Is Enveric Biosciences in the NASDAQ 100?
  • Is Enveric Biosciences in the Dow Jones?
  • When was Enveric Biosciences's last earnings report?
  • When does Enveric Biosciences report earnings?
  • Should I buy Enveric Biosciences stock now?

What is the ticker symbol for Enveric Biosciences?

The ticker symbol for Enveric Biosciences is NASDAQ:ENVB

Does Enveric Biosciences pay dividends?

No, Enveric Biosciences does not pay dividends

What sector is Enveric Biosciences in?

Enveric Biosciences is in the Healthcare sector

What industry is Enveric Biosciences in?

Enveric Biosciences is in the Biotechnology industry

What country is Enveric Biosciences based in?

Enveric Biosciences is headquartered in United States

When did Enveric Biosciences go public?

Enveric Biosciences's initial public offering (IPO) was on May 4, 2015

Is Enveric Biosciences in the S&P 500?

No, Enveric Biosciences is not included in the S&P 500 index

Is Enveric Biosciences in the NASDAQ 100?

No, Enveric Biosciences is not included in the NASDAQ 100 index

Is Enveric Biosciences in the Dow Jones?

No, Enveric Biosciences is not included in the Dow Jones index

When was Enveric Biosciences's last earnings report?

Enveric Biosciences's most recent earnings report was on Mar 31, 2025

When does Enveric Biosciences report earnings?

The next expected earnings date for Enveric Biosciences is May 15, 2025

Should I buy Enveric Biosciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page